SCHEMBL16130330

SCHEMBL16130330

C=CCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)S/C1=N\C(C)C

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 6/20 0.65
▸ S1PR3 Q99500 6/20 0.65
▸ CFTR P13569 1/20 0.61
▸ KMT2A Q03164 2/20 0.53
▸ MITF O75030 1/20 0.53
▸ MAPK1 P28482 2/20 0.52
▸ CA9 Q16790 1/20 0.50
▸ PIM1 P11309 2/20 0.49
▸ CDK5 Q00535 2/20 0.49
▸ CDK5R1 Q15078 2/20 0.49
▸ DYRK2 Q92630 2/20 0.49
▸ MAPT P10636 3/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ CTRC Q99895 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16130325 0.94 S1PR1 (0.65) S1PR1S1PR3CFTRKMT2AMITF
SCHEMBL12912717 0.86 CFTR (0.66) S1PR1S1PR3CFTRKMT2AMITF
SCHEMBL12912678 0.85 S1PR1 (0.62) S1PR1S1PR3CFTRKMT2AMAPK1
SCHEMBL12912676 0.84 S1PR1 (0.60) S1PR1S1PR3CFTRKMT2AMAPK1
SCHEMBL20005672 0.81 MAPK1 (0.72) CFTRKMT2AMITFMAPK1MAPT
SCHEMBL18103053 0.81 MAPK1 (0.72) CFTRKMT2AMITFMAPK1MAPT
SCHEMBL16130282 0.80 TDP1 (0.65) S1PR1S1PR3CFTRKMT2AMITF
SCHEMBL944206 0.79 S1PR3 (0.69) S1PR1S1PR3
SCHEMBL12912633 0.78 MEN1 (0.74) S1PR1S1PR3KMT2AMAPK1CA9
SCHEMBL16130306 0.78 S1PR1 (0.65) S1PR1S1PR3CFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE45174-E1 Thiazolidin-4-one derivatives ACTELION PHARMACEUTICALS LTD. (CH) 2014-09-30 — — US disclosed
Send feedback